The company's board has approved an additional investment up to a maximum of USD 40 million over a period of 24 months for a controlling stake in Stelis, Strides Pharma Science said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30cXDRr
via IFTTT
0 comments:
Post a Comment